Enovis (ENOV) Cash & Equivalents (2010 - 2026)

Enovis (ENOV) has 17 years of Cash & Equivalents data on file, last reported at $33.1 million in Q2 2026.

• Cash & Equivalents for Q2 2026 came in at $33.1 million, down 13.86% year-over-year; the trailing twelve-month figure through Apr 2026 was $33.1 million (down 13.86% YoY), and the FY2025 annual result was $36.4 million, down 24.45% from the prior year.
• Cash & Equivalents retreated to $33.1 million in Q2 2026 per ENOV's latest filing, from $36.4 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $661.5 million in Q2 2022 and troughed at $21.9 million in Q1 2023.
• A 5-year average of $78.2 million and a median of $36.2 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents tumbled 96.69% in 2023, then jumped 202.59% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $24.3 million in 2022, then soared by 48.96% to $36.2 million in 2023, then soared by 33.09% to $48.2 million in 2024, then fell by 24.45% to $36.4 million in 2025, then slipped by 8.96% to $33.1 million in 2026.
• Business Quant data shows ENOV's Cash & Equivalents at $33.1 million in Q2 2026, $36.4 million in Q4 2025, and $33.6 million in Q4 2025.